Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02267863
Title A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aptose Biosciences Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.